BRC
PJP icon

Bell Rock Capital’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bell Rock Capital’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-424
Closed -$28K – 230
2019
Q4 		$28K Sell
424
-166
-28% -$10.1K 0.02% 258
2019
Q3 		$33K Sell
590
-8
-1% -$460 0.03% 233
2019
Q2 		$36K Sell
598
-74
-11% -$4.54K 0.03% 225
2019
Q1 		$45K Buy
672
+3
+0.4% +$197 0.03% 246
2018
Q4 		$44K Buy
669
+56
+9% +$3.78K 0.03% 241
2018
Q3 		$46K Sell
613
-106
-15% -$7.61K 0.02% 256
2018
Q2 		$49K Sell
719
-420
-37% -$27K 0.02% 257
2018
Q1 		$72K Sell
1,139
-86
-7% -$5.66K 0.04% 223
2017
Q4 		$79K Sell
1,225
-127
-9% -$8.14K 0.04% 205
2017
Q3 		$88K Buy
1,352
+165
+14% +$10.4K 0.05% 194
2017
Q2 		$75K Sell
1,187
-293
-20% -$17.6K 0.05% 198
2017
Q1 		$84K Sell
1,480
-1,444
-49% -$84.4K 0.08% 148
2016
Q4 		$164K Buy
+2,924
New +$168K 0.17% 87

Other funds holding PJP

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bell Rock Capital's PJP Position: Q1 2020 in Review

Bell Rock Capital sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2020, closing a stake of 424 shares — an estimated $28K sold.

Bell Rock Capital first reported a position in PJP in Q4 2016 and held it in 13 quarters. The position peaked at $164K in Q4 2016. 86 funds tracked by Wall St. Rank hold PJP as of Q1 2020.

  • Bell Rock Capital reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2020 after selling out during the quarter.
  • Bell Rock Capital sold 424 Invesco Pharmaceuticals ETF shares in Q1 2020, an estimated $28K.
  • Bell Rock Capital first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and held it in 13 quarters.
  • Bell Rock Capital's Invesco Pharmaceuticals ETF position peaked at $164K in Q4 2016.
  • 86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2020.

Based on Bell Rock Capital's 13F filing for Q1 2020, filed 7 May 2020.